PRESS RELEASE published on 07/04/2025 at 18:00, 1 year 1 month ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC's 4 convertible bonds conversion led to a EUR 100,000 capital increase for Oxurion, aiding in focusing on vision preservation for elderly. Updated share capital and voting rights revealed Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion Vision Preservation
PRESS RELEASE published on 07/04/2025 at 18:00, 1 year 1 month ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converte 4 obligaties in Oxurion, wat resulteert in een kapitaalverhoging van EUR 100.000. Deze conversie maakt deel uit van de kapitaaltoezegging van EUR 20 miljoen van Atlas Special Opportunities, LLC aan Oxurion Kapitaalverhoging Atlas Special Opportunities Oxurion Gewone Aandelen Converteerbare Obligaties
BRIEF published on 07/03/2025 at 18:05, 1 year 1 month ago Oxurion Reports Shareholding Changes by Atlas Special Opportunities Transparency Shareholding Legislation Atlas Special Opportunities Oxurion
BRIEF published on 07/03/2025 at 18:05, 1 year 1 month ago Oxurion annonce des changements dans son actionnariat grâce à Atlas Special Opportunities Actionnariat Transparence Legislation Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 07/03/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications, crossing under thresholds due to selling of voting securities. Company combines therapeutic innovation with clinical research technologies Clinical Research Oxurion NV Therapeutic Innovation Transparency Notifications Voting Securities
PRESS RELEASE published on 07/03/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC Oxurion NV (Euronext Brussel: OXUR) annonce des notifications de transparence conformément à la législation belge. Atlas Special Opportunities II LLC a réduit sa participation en dessous des seuils de 5% et 3% Actions Transparence Belgique Oxurion NV Atlas Special Opportunities II LLC
BRIEF published on 06/30/2025 at 18:05, 1 year 1 month ago Oxurion Reports Transparency Notification from Atlas Special Opportunities Transparency Notification Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF published on 06/30/2025 at 18:05, 1 year 1 month ago Oxurion publie une notification de transparence d'Atlas Special Opportunities Actionnariat Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 06/30/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innovation and clinical research technologies Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE published on 06/30/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
Published on 08/07/2026 at 23:15, 10 hours 30 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 10 hours 45 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 11 hours 15 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 11 hours 30 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 10 hours 24 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 14 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 14 hours 30 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 15 hours 35 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 15 hours 45 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 14 hours 51 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 14 hours 51 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 15 hours 4 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 15 hours 4 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 15 hours 45 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026